Retrospective Study on Myoelectric Elbow-Wrist-Hand Orthosis User Outcomes

Myomo21 enrolled

Overview

The objective of this study is to retrospectively evaluate the outcomes and clinical benefits provided by this brace to adult patients with upper limb impairment or paralysis due to brachial plexus, stroke (CVA), spinal cord injury, or other neurological disease or injury. The primary result in this study is a comparison of the Disabilities of the Arm, Shoulder and Hand questionnaire results that were completed before and at least six months after receiving the MyoPro. A retrospective record review will be done to collect data regarding MyoPro user outcomes for individuals that received a MyoPro starting January 2021 and after. Additional data types such as demographics and clinical outcomes will be gathered. Participants may complete at least one follow-up session to record responses to additional inquiries from the research team.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Stroke Brachial Plexus Injury Spinal Cord Injuries Neurological Disease

Interventions

Myoelectric Elbow-Wrist-Hand OrthosisDEVICE

An arm orthosis that uses myoelectric signals to control the level of mechanical assistance provided to a user's elbow and hand in order to overcome upper limb weakness or paralysis and achieve functional tasks.

Eligibility

Sex: ALLMin age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Adults, 65 years and older at the time of MyoPro delivery * Completed the DASH questionnaire at evaluation before receiving the MyoPro * Completed the DASH questionnaire at least six months after receiving the MyoPro * Has intact cognition * Able to clearly and verbally communicate in the English language Exclusion Criteria: * Life-changing event(s) or change(s) in medical status that affected ability to use the MyoPro * Did not complete the DASH after receiving the MyoPro * Other conditions (e.g., cognitive issues) or circumstances that would preclude safe and/or effective participation

Locations (3)

Myomo, Inc.

Boston, Massachusetts, United States

Geauga Rehabilitation Engineering, Inc.

Chardon, Ohio, United States

Orthocare Innovations, LLC

Edmonds, Washington, United States

Outcomes

Primary Outcomes

Disabilities of the Arm, Shoulder and Hand (DASH)

Validated outcome measure that asks an individual to self-report about the ability to perform certain upper limb activities. Questions are responded on a 5-point Likert scale.

Time frame: Pre-MyoPro

Disabilities of the Arm, Shoulder and Hand (DASH)

Validated outcome measure that asks an individual to self-report about the ability to perform certain upper limb activities. Questions are responded on a 5-point Likert scale.

Time frame: At least six months Post-MyoPro

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.